QUÉBEC CITY, Feb. 7, 2012
/PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ)
(the "Company") today announced that Paul Blake, MD, the Company's Senior Vice
President and Chief of Medical Affairs, will be presenting a
Company overview at the BIO CEO Investor Conference on Tuesday, February 14, 2012, at 3:30 pm (Eastern), in the Duke of Windsor Room of the Waldorf Astoria Hotel
in New York City.
Dr. Blake will also take part in a cancer panel during the RBC
Capital Markets Global Healthcare Conference on Tuesday, February 28, 2012 at 11:00 am (Eastern) in the Holmes Room 1 of
the New York Palace Hotel in New
York City.
Live audio webcasts of these presentations will be available on
Aeterna Zentaris' website at www.aezsinc.com, in the Newsroom
section. A replay of the webcasts will also be available on the
Company's website for a period of 90 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a late-stage oncology drug development
company currently investigating potential treatments for various
cancers including colorectal, multiple myeloma, endometrial,
ovarian, prostate and bladder cancer. The Company's innovative
approach of "personalized medicine" means tailoring treatments to a
patient's specific condition and to unmet medical needs. Aeterna
Zentaris' deep pipeline is drawn from its proprietary discovery
unit providing the Company with constant and long-term access to
state-of-the-art therapeutic options. For more information please
visit www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.